Buckley Mortimer J 4

What Happened Mortimer J. Buckley, a director of Pfizer Inc. (PFE), was granted 1,543.845 derivative units (phantom shares) on 2026-06-26. The units are valued at $24.29 each for a total grant value of $37,500. This transaction is an award/grant (code A) representing deferred director compensation rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-06-26 — 1,543.845 units at $24.29 per unit (total $37,500).
• Transaction type: Award/Grant of derivative units (code A).
• Shares/units outstanding after transaction: Not specified in the provided filing excerpt.
• Footnotes: Each unit equals one phantom share of common stock (F1). Units represent deferred director compensation (including dividend equivalents) settled in cash or common stock at the director’s election following retirement from the Board (F2).
• Filing timeliness: Report filed 2026-06-30; this appears timely (filed within the standard two-business-day window).

Context These were phantom share units (deferred compensation) granted to a director, which are typically settled in cash or converted to stock at a future date (often upon retirement). Such awards are compensation, not market purchases or sales, and do not by themselves indicate immediate buying or selling sentiment in the open market.